| Original language | English |
|---|---|
| Article number | 1319028 |
| Journal | OncoImmunology |
| Volume | 6 |
| Issue number | 9 |
| Number of pages | 14 |
| ISSN | 2162-402X |
| DOIs | |
| Publication status | Published - 2017 |
| MoE publication type | A1 Journal article-refereed |
Fields of Science
- Cancer vaccine
- heteroclitic peptides
- immunotherapy
- in silico
- prediction servers
- tumor antigens
- TUMOR-REACTIVE CTL
- T-CELL EPITOPES
- CROSS-REACTIVITY
- IMMUNE-RESPONSES
- PEPTIDE LIGANDS
- VACCINE
- CANCER
- RECOGNITION
- IMMUNOGENICITY
- MELAN-A/MART-1
- 3122 Cancers
Cite this
}
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma. / Capasso, Cristian; Magarkar, Aniket; Cervera-Carascon, Victor; Fusciello, Manlio; Feolaf, Sara; Muller, Martin; Garofalo, Mariangela; Kuryk, Lukasz; Tahtinen, Siri; Pastore, Lucio; Bunker, Alex; Cerullo, Vincenzo.
In: OncoImmunology, Vol. 6, No. 9, 1319028, 2017.Research output: Contribution to journal › Article › Scientific › peer-review
TY - JOUR
T1 - A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma
AU - Capasso, Cristian
AU - Magarkar, Aniket
AU - Cervera-Carascon, Victor
AU - Fusciello, Manlio
AU - Feolaf, Sara
AU - Muller, Martin
AU - Garofalo, Mariangela
AU - Kuryk, Lukasz
AU - Tahtinen, Siri
AU - Pastore, Lucio
AU - Bunker, Alex
AU - Cerullo, Vincenzo
PY - 2017
Y1 - 2017
KW - Cancer vaccine
KW - heteroclitic peptides
KW - immunotherapy
KW - in silico
KW - prediction servers
KW - tumor antigens
KW - TUMOR-REACTIVE CTL
KW - T-CELL EPITOPES
KW - CROSS-REACTIVITY
KW - IMMUNE-RESPONSES
KW - PEPTIDE LIGANDS
KW - VACCINE
KW - CANCER
KW - RECOGNITION
KW - IMMUNOGENICITY
KW - MELAN-A/MART-1
KW - 3122 Cancers
U2 - 10.1080/2162402X.2017.1319028
DO - 10.1080/2162402X.2017.1319028
M3 - Article
VL - 6
JO - OncoImmunology
JF - OncoImmunology
SN - 2162-4011
IS - 9
M1 - 1319028
ER -